Combined therapy in treatment of macular oedema in retinal vein occlusion
Article Sidebar
Main Article Content
Abstract
Retinal vein occlusion and the complications which arise from it, next to diabetic macular oedema, is the most common vascular disease in retina, witch can lead to significant visual loss. Treatment of retinal vein occlusion complications, both central retinal vein occlusion and branch retinal vein occlusion are still difficult, though many alternative forms of treatment exist. The aim of the study is to present two clinical cases after combined therapy: intravitreal ranibizumab and laser therapy by yellow laser of 577 nm wave lenght (Integre Yellow Ellex).
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright: © Medical Education sp. z o.o. License allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
References
2. Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch Ophthalmol. 1996; 114: 1243-7.
3. Hayreh S, Zimmerman M, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol. 1994; 117: 429-41.
4. Rogers S, McIntosh RL, Cheung N et al. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology. 2010; 117: 313-9.
5. McIntosh RL, Rogers SL, Lim L et al. Natural history of central retinal vein occlusion: an evidence-based systematic review. Ophthalmology. 2010; 117: 1113-23.
6. The Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol. 1997; 115: 486-91.
7. Brown DM, Campochiaro PA, Singh RP et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology. 2010; 117: 1124-33.
8. Todorich B, Lin P, Shieh C et al. Efficacy of aflibercept for the treatment of chronic non-ischemic CRVO associated macular edema after treatment with other anti-VEGF agents. J Eye Ophthalmol. 2014; 1: 3.
9. Jung SH, Kim K, Sohn SW et al. Association of aqueous humor cytokines with the development of retinal ischemia and recurrent macular edema in retinal vein occlusion. Invest Ophthalmol VIS SCI. 2014; 4: 2290-6.
10. Haller JA, Bandello F, Belfort R Jr et al.; OZURDEX GENEVA Study Group. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 2010; 117(6): 1134-46.
11. The SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch Ophthalmol. 2009; 127: 1101-4.
12. The Central Vein Occlusion Study Group M report. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. Ophthalmology. 1995; 102: 1425-33.
13. The Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol. 1984; 98(3): 271-82.
14. Luttrull JK, Dorin G. Subthreshold Diode Micropulse Laser Photocoagulation (SDM) as Invisible Retinal Phototherapy for Diabetic Macular Edema: A Review Curr Diabetes Rev. 2012; 8(4): 274-84.
15. Noma H, Mimura T, Shimada K. Changes of macular sensitivity and morphology after pars plana vitrectomy for macular edema with central retinal vein occlusion: a case series. BMC Ophthalmology. 2013; 13: 2.
16. DeCroos FC, Shuler RK Jr, Stinnett S et al. Pars plana vitrectomy, internal limiting membrane peeling, and panretinal endophotocoagulation for macular edema secondary to central retinal vein occlusion. Am J Ophthalmol. 2009; 147(4): 627-33.